Literature DB >> 31492535

A nationwide observational study of locomotive syndrome in Japan using the ResearchKit: The Locomonitor study.

Yusuke Yoshimura1, Muneaki Ishijima2, Masayoshi Ishibashi3, Liz Liu4, Eri Arikawa-Hirasawa5, Shuichi Machida6, Hisashi Naito6, Chieko Hamada7, Eiki Kominami8.   

Abstract

BACKGROUND: We developed the Locomonitor application (app), the world's first iOS app to study locomotive syndrome, using the ResearchKit and examined the prevalence and risk factors for locomotive syndrome in Japanese general individuals 20-69 years old in a nationwide cross-sectional observational study.
METHODS: The participants were recruited from February to August 2016. The outcome measures for the locomotive function were evaluated by locomotive syndrome risk tests (LSRTs) using the Locomonitor app. The chi-squared test, a linear-by-linear association trend analysis, and Spearman's correlation test were performed as statistical analyses.
RESULTS: A total of 2177 subjects from all prefectures in Japan were included (average 42.2 years old). The Locomo25 and Stand-Up test scores in female participants and the Two-Step test scores in male participants showed age-dependent deterioration. In the overall population, the incidence of Locomo stage 1 and 2, as evaluated by the Locomo25, Stand-Up test or Two-Step test, was 30.2% and 29.2%, respectively. In subjects without locomotive syndrome (40.5%), LSRT scores showed age-dependent deterioration in both sexes. Locomotive syndrome in participants with a body mass index (BMI) of ≥25 kg/m2 was more frequent than in those with a BMI of <25 kg/m2 (age- and gender-adjusted odds ratio [OR] 1.344 [95% confidence interval {CI} 1.03-1.75, p = 0.027]). Locomotive syndrome in participants with an exercise habit was less frequent than in those without an exercise habit (age- and gender-adjusted OR 0.499 [95% CI 0.33-0.755, p < 0.0001]).
CONCLUSIONS: The Locomonitor app, a newly developed remote platform, revealed that approximately 20%-30% of Japanese individuals 20-69 years old in the general population met the definition of locomotive syndrome. Locomotive syndrome in participants with obesity was more frequent than those without obesity, while locomotive syndrome in participants with an exercise habit was less frequent than those without an exercise habit.
Copyright © 2019 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31492535     DOI: 10.1016/j.jos.2019.08.009

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  6 in total

1.  Development of locomotive syndrome in elderly population after COVID-19 outbreak: A population-based cross-sectional study with over 12,000 participants.

Authors:  Hidetomi Terai; Koji Tamai; Shinji Takahashi; Hiroshi Katsuda; Nagakazu Shimada; Yusuke Hori; Yuto Kobayashi; Hiroaki Nakamura
Journal:  J Orthop Sci       Date:  2022-06-06       Impact factor: 1.805

2.  Reductions in the Frequency of Going Out Due to the COVID-19 Pandemic Negatively Affect Patients with Spinal Disorders.

Authors:  Hidetomi Terai; Masayoshi Iwamae; Koji Tamai; Shinji Takahashi; Yusuke Hori; Shoichiro Ohyama; Akito Yabu; Masatoshi Hoshino; Hiroaki Nakamura
Journal:  Spine Surg Relat Res       Date:  2021-09-09

3.  Is locomotion training effective for middle-aged workers?

Authors:  Akinobu Nishimura; Makoto Ohtsuki; Toshihiro Kato; Rie Nagao-Nishiwaki; Yoshiyuki Senga; Ko Kato; Toru Ogura; Akihiro Sudo
Journal:  J Occup Health       Date:  2021-01       Impact factor: 2.708

4.  A Versatile and Scalable Platform That Streamlines Data Collection for Patient-Centered Studies: Usability and Feasibility Study.

Authors:  Haley Huang; Hussein Ezzeldin; Sofia Aschettino; Nasim Lari; Ting-Hsuan Lee; Sarah Stothers Rosenberg; Xinyi Ng; Stella Muthuri; Anirudh Bakshi; Korrin Bishop
Journal:  JMIR Form Res       Date:  2022-09-14

5.  Awareness of Locomotive Syndrome and Factors Associated with Awareness: A Community-Based Cross-Sectional Study.

Authors:  Keiko Sugai; Haruhiko Imamura; Takehiro Michikawa; Keiko Asakura; Yuji Nishiwaki
Journal:  Int J Environ Res Public Health       Date:  2020-10-05       Impact factor: 3.390

6.  The FDA MyStudies app: a reusable platform for distributed clinical trials and real-world evidence studies.

Authors:  Zachary Wyner; Sascha Dublin; Christina Chambers; Shyam Deval; Chayim Herzig-Marx; Shanthala Rao; Adam Rauch; Juliane Reynolds; Jeffrey S Brown; David Martin
Journal:  JAMIA Open       Date:  2020-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.